also i d like to apologize if my edit description for re adding the anxiety disorders was unnecessarily provocative to be honest i was surprised to see all mention of several approved indications for the drug removed from the article over a sourcing issue when the approval itself could be viewed as representing a secondary source my thought was that this situation was a little different from one in which weak sources are used to support fringe claims